United States (National)

Kasowitz Benson Torres continues to distinguish itself as one of New York's leading litigation-focused firms, with strengths spanning securities, antitrust, white-collar and complex commercial disputes. The firm remains a destination for clients facing their most consequential matters. Firm lawyers emphasize a willingness to pursue difficult and often novel disputes, noting that trial remains central to the firm's approach.

Founding partner Marc Kasowitz continues to play a prominent role in the firm's most significant representations. In a closely watched political corruption prosecution in recent U.S. history, Kasowitz, alongside the firm’s white collar team, represented Jose Uribe, the government's key cooperating witness in the prosecution of former Senator Bob Menendez. Despite Uribe facing a statutory maximum sentence of 95 years, the team secured a sentence of no jail time following what prosecutors described as exceptional cooperation. Uribe's testimony proved central to the government's successful prosecution of Menendez and other defendants, generating extensive national media coverage and underscoring the firm's capabilities in high-profile white-collar matters.

Another cornerstone of the firm's practice is its longstanding representation of Teva Pharmaceuticals across securities, antitrust, and white-collar matters. Sheron Korpus continues to lead the firm's defense of Teva and its directors and officers. Following a $420 million settlement of the underlying securities class action, the Kasowitz team has resolved 19 of the 20 related opt-out actions, with a single matter remaining scheduled for trial. Korpus also serves as lead counsel in sprawling pharmaceutical antitrust litigation alleging price-fixing involving more than 100 generic drugs, one of the largest antitrust proceedings currently active in the United States.

The firm's securities litigation practice continues to be driven by Stephen Tountas, who remains active in sophisticated shareholder and market-manipulation disputes. Tountas has developed a particular focus on emerging claims involving spoofing and algorithmic trading while also representing investors and stakeholders in complex bankruptcy-related securities matters. His practice reflects the firm's continued ability to adapt to evolving litigation trends in increasingly technology-driven markets.

The firm's commercial litigation capabilities are reinforced by Christine Montenegro, whose practice spans legal malpractice, insurance recovery, and antitrust disputes. Montenegro recently filed a widely publicized legal malpractice action and remains active in cyber-insurance recovery matters as companies increasingly seek coverage for business disruptions and cyber-related losses.

A new generation of leaders is also becoming increasingly prominent within the firm. Andrew Schwartz has expanded his role across securities and commercial litigation while building an independent practice that includes arbitration and civil-rights matters. Meanwhile, Amit Vora, a former Assistant Solicitor General of New York, continues to grow the firm's appellate platform and is increasingly involved in shaping litigation strategy from the earliest stages of disputes.

Combining headline-grabbing white-collar matters, major pharmaceutical litigation and a deep bench of trial lawyers, Kasowitz continues to demonstrate the breadth and versatility that have long made it one of New York's premier litigation-focused firms.


Updated October 2026